|
Solid Biosciences Inc. (SLDB) DCF -Bewertung
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Solid Biosciences Inc. (SLDB) Bundle
Verbessern Sie Ihre Anlagestrategien mit dem DCF -Taschenrechner von Solid Biosciences Inc. (SLDB)! Erforschen Sie die Finanzdaten für solide Biosources, stellen Sie Wachstumsprojektionen und -kosten an und beobachten Sie sofort, wie sich diese Modifikationen auf den inneren Wert von Solid Biosciences Inc. (SLDB) auswirken.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | 13.6 | 8.1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | -40.57 | -100 | -35.14 | -35.14 | -35.14 | -35.14 | -35.14 |
| EBITDA | -116.5 | -84.4 | -69.3 | -96.9 | -93.4 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | -508.74 | -1196.76 | 100 | 20 | 20 | 20 | 20 | 20 |
| Depreciation | 2.8 | 3.9 | 3.0 | 2.4 | 2.6 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 21.76 | 29.75 | 100 | 70.3 | 70.3 | 70.3 | 70.3 | 70.3 |
| EBIT | -119.3 | -88.3 | -72.3 | -99.3 | -96.0 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | -530.5 | -1226.51 | 100 | 20 | 20 | 20 | 20 | 20 |
| Total Cash | 83.5 | 154.7 | 207.8 | 213.7 | 123.6 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 0.80764 | 0 | 100 | 60.16 | 60.16 | 60.16 | 60.16 | 60.16 |
| Inventories | .0 | .0 | 6.0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 44.16 | 0 | 100 | 68.83 | 68.83 | 68.83 | 68.83 | 68.83 |
| Accounts Payable | 7.1 | 3.3 | 4.5 | 3.2 | 2.0 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 32.77 | 40 | 100 | 74.55 | 74.55 | 74.55 | 74.55 | 74.55 |
| Capital Expenditure | -4.4 | -.9 | -1.3 | -3.0 | -1.5 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | -9.41 | -37.25 | 100 | -9.33 | -9.33 | -9.33 | -9.33 | -9.33 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -117.7 | -90.1 | -72.2 | -75.6 | -96.0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -112.1 | -90.9 | -75.4 | -71.3 | -96.2 | -2.0 | .0 | .0 | .0 | .0 |
| WACC, % | 11.68 | 11.69 | 11.69 | 11.51 | 11.69 | 11.65 | 11.65 | 11.65 | 11.65 | 11.65 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -2 | |||||||||
| Net Debt | -48 | |||||||||
| Equity Value | 46 | |||||||||
| Diluted Shares Outstanding, MM | 20 | |||||||||
| Equity Value Per Share | 2.31 |
What You Will Get
- Comprehensive SLDB Financial Data: Pre-loaded with Solid Biosciences' historical and projected figures for detailed analysis.
- Customizable Template: Easily adjust key metrics such as revenue growth, WACC, and EBITDA %.
- Instant Calculations: Watch Solid Biosciences' intrinsic value refresh immediately based on your adjustments.
- Expert Valuation Tool: Tailored for investors, analysts, and consultants aiming for precise DCF outcomes.
- Intuitive Design: Clear layout and straightforward instructions suitable for users of all skill levels.
Key Features
- Comprehensive DCF Calculator: Offers in-depth unlevered and levered DCF valuation models tailored for Solid Biosciences Inc. (SLDB).
- WACC Calculator: Features a ready-to-use Weighted Average Cost of Capital sheet with adjustable parameters.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit your analysis.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Solid Biosciences Inc. (SLDB).
- Interactive Dashboard and Charts: Visual representations provide a summary of essential valuation metrics for straightforward analysis.
How It Works
- 1. Access the Template: Download and open the Excel file containing Solid Biosciences Inc.'s (SLDB) preloaded data.
- 2. Modify Assumptions: Adjust key inputs such as growth projections, WACC, and capital expenditures.
- 3. View Results Instantly: The DCF model automatically calculates intrinsic value and NPV based on your inputs.
- 4. Explore Scenarios: Evaluate various forecasts to assess different valuation results.
- 5. Present with Assurance: Share professional valuation insights to enhance your decision-making process.
Why Choose This Calculator for Solid Biosciences Inc. (SLDB)?
- Comprehensive Tool: Integrates DCF, WACC, and financial ratio analyses tailored for biotech companies.
- Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios for SLDB.
- Detailed Insights: Automatically computes Solid Biosciences’ intrinsic value and Net Present Value.
- Preloaded Data: Historical and projected data provide reliable starting points for analysis.
- Professional Quality: Perfect for financial analysts, investors, and biotech consultants focused on SLDB.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Solid Biosciences Inc. (SLDB) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models for Solid Biosciences Inc. (SLDB).
- Consultants: Deliver professional valuation insights on Solid Biosciences Inc. (SLDB) to clients quickly and accurately.
- Business Owners: Understand how biotech companies like Solid Biosciences Inc. (SLDB) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to Solid Biosciences Inc. (SLDB).
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Solid Biosciences Inc. (SLDB).
- Real-World Data: Solid Biosciences' historical and projected financials preloaded for analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to simulate various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Charts and tables providing clear, actionable results for decision-making.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.